True North Advisors, LLC Pfizer Inc Transaction History

True North Advisors, LLC

$378 Million
Q3 2024

A detailed history of True North Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, True North Advisors, LLC holds 51,922 shares of PFE stock, worth $1.33 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

51,922

Previous 53,383 2.74%

Holding current value

$1.33 Million

Previous $1.49 Million 0.6%

% of portfolio

0.4%

Previous 0.4%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$27.7 - $31.39 $40,469 - $45,860	-1,461 Reduced 2.74%	51,922 $1.5 Million
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $12,882 - $15,096	510 Added 0.96%	53,383 $1.49 Million
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $29,229 - $33,565	-1,129 Reduced 2.09%	52,873 $1.47 Million
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $11,052 - $14,356	423 Added 0.79%	54,002 $1.55 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $18,997 - $22,205	-592 Reduced 1.09%	53,579 $1.78 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $819,562 - $948,215	-22,690 Reduced 29.52%	54,171 $1.99 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $226,571 - $294,962	-5,752 Reduced 6.96%	76,861 $3.14 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $32,606 - $42,564	781 Added 0.95%	82,613 $4.23 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $20,523 - $25,053	-469 Reduced 0.57%	81,832 $3.58 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $5,350 - $6,344	115 Added 0.14%	82,301 $4.32 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $91,683 - $113,606	-2,004 Reduced 2.38%	82,186 $4.25 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $228,458 - $338,651	5,529 Added 7.03%	84,190 $4.97 Million
Q3 2021 Jun 07, 2022	BUY	$39.25 - $50.42 $95,456 - $122,621	2,432 Added 3.19%	78,661 $3.38 Million
Q2 2021 Jun 07, 2022	SELL	$35.91 - $40.68 $21,222 - $24,041	-591 Reduced 0.77%	76,229 $2.99 Million
Q1 2021 Jun 07, 2022	BUY	$33.49 - $37.77 $4,219 - $4,759	126 Added 0.16%	76,820 $2.78 Million
Q4 2020 May 20, 2022	SELL	$33.47 - $42.56 $277,533 - $352,907	-8,292 Reduced 9.76%	76,694 $2.82 Million
Q3 2020 May 20, 2022	BUY	$31.75 - $37.25 $77,343 - $90,741	2,436 Added 2.95%	84,986 $3.12 Million
Q2 2020 May 20, 2022	BUY	$30.12 - $36.54 $369,361 - $448,090	12,263 Added 17.45%	82,550 $2.7 Million
Q1 2020 May 12, 2022	BUY	$27.03 - $38.62 $27,516 - $39,315	1,018 Added 1.47%	70,287 $2.29 Million
Q4 2019 May 12, 2022	BUY	$32.92 - $37.36 $2.28 Million - $2.59 Million	69,269 New	69,269 $2.71 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Account

True North Advisors, LLC Pfizer Inc Transaction History